The importance of reducing risk in peanut allergy: Current and future therapies

Wayne G. Shreffler, Joe L. Baumert, Benjamin C. Remington, Stef J. Koppelman, Chitra Dinakar, David M. Fleischer, Edwin Kim, Stephen A. Tilles, Jonathan M. Spergel

Research output: Contribution to journalArticle

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)124-127
Number of pages4
JournalAnnals of Allergy, Asthma and Immunology
Volume120
Issue number2
DOIs
StatePublished - Feb 2018

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Cite this

Shreffler, W. G., Baumert, J. L., Remington, B. C., Koppelman, S. J., Dinakar, C., Fleischer, D. M., Kim, E., Tilles, S. A., & Spergel, J. M. (2018). The importance of reducing risk in peanut allergy: Current and future therapies. Annals of Allergy, Asthma and Immunology, 120(2), 124-127. https://doi.org/10.1016/j.anai.2017.10.038